Table 7.
Summary of antipsychotic treatment as maintenance therapy
| Egypt (n=480) | Saudi Arabia (n=333) | Gulf States (n=244) | Overall (n=1,057) | |
|---|---|---|---|---|
| SGA prescribed as maintenance therapy, n (%) | 447 (93.1) | 316 (94.9) | 229 (93.9) | 992 (93.9) |
| 95% CIa | (90.5–95.2) | (92.0–97.0) | (90.1–96.5) | (92.2–95.2) |
| Same SGA used during hospitalization and at discharge,b n (%) | ||||
| Yes | 381 (83.0) | 268 (84.3) | 208 (88.9) | 857 (84.8) |
| No | 78 (17.0) | 50 (15.7) | 26 (11.1) | 154 (15.2) |
Notes:
a
Normal approximation for the proportion of the population with SGA medication as maintenance therapy.
b
Denominator is the number of patients treated with SGA medication during hospitalization. Gulf States, represents combined data from Kuwait and the United Arab Emirates.
Abbreviations: SGA, second-generation antipsychotic; CI, confidence interval.